Article
Cytochrome P450 (CYP2C9*2,*3) & vitamin-K epoxide reductase complex (VKORC1 -1639G<A) gene polymorphisms & their effect on acenocoumarol dose in patients with mechanical heart valve replacement.
The Indian journal of medical research - 1 Jan 2013
Kaur Anupriya, Khan Farah, Agrawal Suraksha S, Kapoor Aditya, Agarwal Surendra K, Phadke Shubha R
Abstract excerpt
BACKGROUND & OBJECTIVES: Studies have demonstrated the effect of CYP2C9 (cytochrome P450) and VKORC1 (vitamin K epoxide reductase complex) gene polymorphisms on the dose of acenocoumarol. The data from India about these gene polymorphisms and their effects on acenocoumarol dose are scarce. The aim of this study was to determine the occurrence of CYP2C9*2,*3 and VKORC 1 -1639G>A gene polymorphisms and to study...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.